Syros Pharmaceuticals, Inc.
Records under this name other than the patents Syros Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
Back to Syros Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,906,889 | Polycyclic Inhibitors of Cyclin-Dependent Kinase 7 (CDK7) Formerly held In force · High confidence | In force | High confidence | |
| US 11,040,957 | Heteroaromatic Compounds Useful for the Treatment of Proliferative Diseases Formerly held In force · High confidence | In force | High confidence | |
| US 10,272,045 | High Surface-Area Lyophilized Compositions Comprising Arsenic for Oral Administration in Patients Formerly held In force · High confidence | In force | High confidence | |
| US 10,653,628 | High Surface-Area Lyophilized Compositions Comprising Arsenic for Oral Administration in Patients Formerly held In force · High confidence | In force | High confidence | |
| US 12,364,664 | Lyophilized compositions comprising arsenic Formerly held In force · High confidence | In force | High confidence | |
| US 10,111,836 | High Surface-Area Lyophilized Compositions Comprising Arsenic for Oral Administration in Patients Formerly held In force · High confidence | In force | High confidence | |
| US 10,738,067 | Inhibitors of Cyclin-Dependent Kinase 7 (CDK7) Formerly held In force · High confidence | In force | High confidence | |
| US 11,918,592 | Inhibitors of Cyclin Dependent Kinase 7 (CDK7) Formerly held In force · High confidence | In force | High confidence | |
| US 12,240,869 | Inhibitors of Cyclin-Dependent Kinase 7 (CDK7) Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,106,526 | Inhibitors of Cyclin-Dependent Kinase 7 (CDK7) Lapsed on the fee record Ended Oct 23, 2026 · Low confidence | Lapsed on the fee record | Ended Oct 23, 2026 | Low confidence |